National and Kapodistrian University of Athens
O ρόλος των κλινικών επιδράσεων του IRL-1620 σε πειραματικό μοντέλο τραυματισμού του νωτιαίου μυελού
Abstract
dc:descriptionBackground: Spinal Cord Injury (SCI) presents a major global health challenge, with rising incidence and substantial disability. While progress has been made in understanding SCI's pathophysiology and early management, there is still a lack of effective treatments to mitigate long-term consequences. This study investigates the potential of sovateltide, a selective endothelin B (ETB) receptor agonist, in improving clinical outcomes in an acute SCI rat model. Methods: Thirty male Sprague-Dawley rats underwent sham surgery (Group A) or spinal cord injury (SCI) and treated with vehicle (Group B) or sovateltide (Group C). Clinical tests, including Basso, Beattie, and Bresnahan (BBB) scoring, inclined plane, and allodynia testing with Von Frey Hair, were performed at various time points. Statistical analyses assessed treatment effects. Results: Sovateltide administration significantly improved motor function, reducing neurological deficits and enhancing locomotor recovery compared to vehicle-treated rats, starting from day 7 post-injury. Additionally, the allodynic threshold improved, suggesting anti-nociceptive properties. Notably, the sovateltide group demonstrated sustained recovery, and even reaching pre-injury performance levels, while the vehicle group plateaued. Conclusions: This study suggests that sovateltide may offer neuroprotective effects, enhancing neurogenesis and angiogenesis. Furthermore, it may possess anti-inflammatory and anti-nociceptive properties. Future clinical trials are needed to validate these findings, but sovateltide shows promise as a potential therapeutic strategy to improve functional outcomes in SCI. Sovateltide, an ETB receptor agonist, exhibits neuroprotective properties, enhancing motor recovery and ameliorating hyperalgesia in a rat SCI model. These findings could pave the way for innovative pharmacological interventions for SCI in clinical settings.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2024
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Mavridis, Theodoros
- Μαυρίδης, Θεόδωρος
Subjects
dc:subject × 16- Αλλοδυνία
- Αγωνιστής υποδοχέων ETB
- IRL-1620
- Νευροπροστατευτική θεραπεία
- Θεραπεία τραυματισμού νωτιαίου μυελού
- Allodynia
- ETB receptor agonist
- ILR-1620
- Neuroprotective therapy
- Spinal cord injury treatment
- Βασική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Νευροεπιστήμες
- Basic Medicine
- Medical and Health Sciences
- Neurosciences
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/56507